Home - Products - Others - Other Targets - (3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone

(3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone

CAS No. ———

(3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone( ——— )

Catalog No. M38494 CAS No. ———

(3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
25MG	Get Quote	Get Quote
50MG	Get Quote	Get Quote
100MG	Get Quote	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

(3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone
Note

Research use only, not for human use.
Brief Description

(3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone
Description

(3β,7β)-3,7,20,21-Tetrahydroxy-11,15-dioxo-lanosta-8-en-24→20 lactone
In Vitro

———
In Vivo

———
Synonyms

———
Pathway

Others
Target

Other Targets
Recptor

———
Research Area

———
Indication

———

Chemical Information

CAS Number

———
Formula Weight

———
Molecular Formula

———
Purity

>98% (HPLC)
Solubility

———
SMILES

———
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

MMP-1 Substrate I, f...

MMP-1 Substrate I, fluorogenic
Emicizumab

Emicizumab(ACE 910) is a bispecific monoclonal antibody that bridges activated factor IX and activated factor X to mimic the function of activated factor VIII. Emicizumab is used for the prevention and treatment of hemophilia A.
Jatairidoid B

The herbs of Valeriana jatamansi.

Sign In Join Free